source
- Biopharma M&A stays robust as companies shift focus from megadeals to smaller targetsThe article notes that despite a slowdown in large megadeals, overall merger and acquisition activity in the biopharma sector remains strong. Companies are adopting multi‑pronged strategies to add…
- PSA Blood Test Found to Lower Prostate Cancer Deaths, Review ShowsA new Cochrane review concludes that prostate-specific antigen (PSA) screening is likely to reduce deaths caused by prostate cancer. The analysis combined data from six trials involving roughly 80…